JDD March 2026 Issue Highlights
The March issue of the Journal of Drugs in Dermatology (JDD) gathers a timely, practice‑oriented collection of studies and reports selected as this month’s Editor’s Picks — spanning potential disease‑modifying implications of antiviral therapy, long‑term biologic data, evolving topical and systemic options for inflammatory skin disease, and a range of hair‑ and nail‑focused investi …
The March issue of the Journal of Drugs in Dermatology (JDD) gathers a timely, practice‑oriented collection of studies and reports selected as this month’s Editor’s Picks — spanning potential disease‑modifying implications of antiviral therapy, long‑term biologic data, evolving topical and systemic options for inflammatory skin disease, and a range of hair‑ and nail‑focused investi … 
At the 2026 ODAC Dermatology Conference in Orlando, Dr. Misty Eleryan, Clinical Assistant Professor of Dermatology at George Washington University and Director of Mohs Surgery and Cutaneous Oncology at Chosen Dermatology in Los Angeles, California, presented her talk “Sun Protection 2.0: Advances in UV Filters, Blue Light Defense, & Beyond” which detailed new developments in our understand … 
A 55-year-old female presents with concerns about plaques on both of her eyelids. Which of the following statements is true regarding this patient's skin condition?
A. These are the least common type of xanthoma
B. Most commonly associated with hyperglycemia
C. Lesions arise asymmetrically
D. Lesions start off as many bumps that grow rapidly
E. Lesions are soft, velvety, yellowi … 
A review in Cosmopolitan addressed questions about the safety of radiofrequency (RF) microneedling. Last fall, the FDA issued a safety communication about potential risks with “certain uses” of the devices. The FDA received reports that some RF microneedling patients were burned, scarred, or disfigured, or experienced fat loss or nerve damage. In the article, beauty director Lauren Balsamo sha … 
New research is supporting the use of two innovative products for acne: a triple combination therapy and the first new molecule for acne in 40 years. In this Next Steps in Derm interview, in partnership with the ODAC Dermatology Conference, Brooklyn, N.Y., dermatologist Dr. Hilary Baldwin outlines the latest acne studies and how these new treatments are helping dermatology clinicians address the f …